The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - BioMed Valley Discoveries (I); Esperion Therapeutics (I); Takeda (I)
Research Funding - Astex Pharmaceuticals (Inst); GlaxoSmithKline (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); OncoMed (Inst); Pfizer (Inst)
Comprehensive genomic profiling of 298 lung cancers of varying histologies harboring MET exon 14 alterations.
 
Sai-Hong Ignatius Ou
Honoraria - Pfizer; Roche Pharma AG
Consulting or Advisory Role - Pfizer; Roche/Genentech
Speakers' Bureau - Boehringer Ingelheim; Genentech
Research Funding - ARIAD (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Chugai Pharma (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Peregrine Pharmaceuticals (Inst); Pfizer (Inst); Roche Pharma AG (Inst)
 
Garrett Michael Frampton
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
James Suh
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Zachary Rockow Chalmers
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Mark Rosenweig
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Jonathan Wade Goldman
Honoraria - Clovis Oncology; Genentech
Research Funding - ArQule; Astex Pharmaceuticals; AstraZeneca/MedImmune; Bristol-Myers Squibb; Clovis Oncology; Genentech/Roche; Lilly; Synta
 
Patrick M. Forde
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Celgene; Seagen
 
Kurt Leuenberger
No Relationships to Disclose
 
Nir Peled
Honoraria - AstraZeneca; Bristol-Myers Squibb; Lilly; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Early detection of lung cancer by exhaled breath technology (Inst); Radiation technique (Inst); Radiosensitizier (Inst)
 
Gregory Kalemkerian
No Relationships to Disclose
 
Jeffrey S. Ross
Employment - Foundation Medicine
Leadership - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Pfizer
Research Funding - Foundation Medicine
 
Philip J. Stephens
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Vincent A. Miller
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Siraj Mahamed Ali
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Alexa Betzig Schrock
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine